[Herald Interview] Seegene to launch single-platform disease detection in 2017, CEO says
Dec 11, 2016
South Korean biotech company Seegene plans to make an aggressive push into the US and European markets by launching hundreds of molecular diagnostic assays enabling early detection of various diseases from flu to cancer on a single platform from next year.Seegene, a developer of multiplex molecular technologies, is set to implement a breakthrough technology -- an automation of reagent development system to reduce development time significantly from a year to weeks. “Molecular tests allow timely